A Massachusetts man is the only one in the country who has tried a nasal spray treatment for Alzheimer's. He's going to help ...
The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.
The global landscape of neurological health is undergoing a transformative moment with a pioneering nasal spray that could potentially revolutionize Alzheimer‘s disease management. As ...
The U.S. Food and Drug Administration is recalling 89,312 bottles of NasoGel nasal spray because the product might cause ...
Compared with placebo, zavegepant nasal spray yielded sustained relief of acute pain and function in migraine.
Almost 100,000 bottles of nasal spray were recalled for a "microbial failure" that led to multiple complaints from customers.
The recalled products were sold across 32 states — including Massachusetts, Connecticut, Rhode Island and Vermont.
A Prescription Drug User Fee Act target date of September 14, 2025 has been assigned to the application. The Food and Drug Administration (FDA) has accepted for review the New Drug Application ...
The neffyinSchools program from ARS Pharma will provide eligible public and private K-12 schools in the United States with ...
If you suffer from allergies or sinus congestion, you might want to think twice before using this nasal spray. The U.S. Food and Drug Administration is recalling 89,312 bottles of NasoGel nasal ...
Nasal spray is being recalled over microbial failure. The U.S. Food and Drug Administration shared information about the recall affecting NeilMed Pharmaceuticals’ NasoGel Spray, last week.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results